2021 BQ Journal Vol 42 - 10

PREVENTING CHRONIC DISEASE
PUBLIC

HEALTH

RESEARCH,

PRACTICE,

Volume 17, E123

AND

POLICY

OCTOBER 2020
ORIGINAL RESEARCH

Preventing Breast, Cervical, and Colorectal
Cancer Deaths: Assessing the Impact of
Increased Screening
Krishna P. Sharma, PhD1; Scott D. Grosse, PhD2; Michael V. Maciosek, PhD3; Djenaba Joseph, MD, MPH1;
Kakoli Roy, PhD4; Lisa C. Richardson, MD, MPH1; Harold Jaffe, MD5
Accessible Version: www.cdc.gov/pcd/issues/2020/20_0039.htm

leads initiatives to increase breast, cervical, and colorectal cancer
(CRC) screening. We assessed the number of avoidable deaths
from increased screening, according to USPSTF recommendations, for CRC and female breast and cervical cancers.

Suggested citation for this article: Sharma KP, Grosse SD,
Maciosek MV, Joseph D, Roy K, Richardson LC, et al.
Preventing Breast, Cervical, and Colorectal Cancer Deaths:
Assessing the Impact of Increased Screening. Prev Chronic Dis
2020;17:200039. DOI: https://doi.org/10.5888/pcd17.200039.

Methods

We used model-based estimates of avoidable deaths for the lifetime of single-year age cohorts under the current and increased use
of screening scenarios (data year 2016; analysis, 2018). We calculated prevented cancer deaths for each 1% increase in screening
uptake and extrapolated to current level of screening (2016), current level plus 10 percentage points, and increasing screening to
90% and 100% of the eligible population.

PEER REVIEWED
Summary
What is already known on this topic?
Screening for colorectal cancer and for female breast and cervical cancers can effectively reduce deaths from these cancers. Yet many preventive services, including cancer screening, remain underutilized in the United
States.

Results

Increased use of screening from current levels to 100% would prevent an additional 2,821 deaths from breast cancer, 6,834 deaths
from cervical cancer, and 35,530 deaths from CRC over a lifetime
of the respective single-year cohort. Increasing use of CRC
screening would prevent approximately 8.5 times as many deaths
as the equivalent increase in use of breast cancer screening (women only), although twice as many people (men and women)
would have to be screened for CRC.

What is added by this report?
Increased use of screening from current levels to 100% would prevent an
additional 2,821 deaths from breast cancer, 6,834 deaths from cervical
cancer, and 35,530 deaths from colorectal cancer over a lifetime of the respective single-year cohort. Increasing use of colorectal cancer screening
would prevent more deaths than an equivalent increase in breast and cervical cancer screening.
What are the implications for public health practice?
Public health programs incorporating strategies shown to be effective can
help increase screening rates. Organized screening approaches leveraging partnerships between public health and primary health care to implement such strategies could be used to reduce the prevalence of these
cancers.

Conclusions

A large number of deaths could be avoided by increasing breast,
cervical, and CRC screening. Public health programs incorporating strategies shown to be effective can help increase screening
rates.

Abstract

Introduction

Introduction

The US Preventive Services Task Force (USPSTF) recommends
select clinical preventive services with " A " and " B " recommendation grades for the eligible population. A grade " A " recommendation reflects high certainty of substantial net benefit from a ser-

The US Preventive Services Task Force (USPSTF) recommends
select preventive clinical services, including cancer screening.
However, screening for cancers remains underutilized in the
United States. The Centers for Disease Control and Prevention

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health
and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions.

www.cdc.gov/pcd/issues/2020/20_0039.htm * Centers for Disease Control and Prevention
This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.

Diagnostics I Pharmaceuticals I DxRx Solutions I Continuing Education I News
A Henry Schein Publication

10

1


http://www.cdc.gov/pcd/issues/2020/20_0039.htm https://www.doi.org/10.5888/pcd17.200039 http://www.cdc.gov/pcd/issues/2020/20_0039.htm

2021 BQ Journal Vol 42

Table of Contents for the Digital Edition of 2021 BQ Journal Vol 42

Table of Contents
2021 BQ Journal Vol 42 - Cover1
2021 BQ Journal Vol 42 - 2
2021 BQ Journal Vol 42 - Table of Contents
2021 BQ Journal Vol 42 - 4
2021 BQ Journal Vol 42 - 5
2021 BQ Journal Vol 42 - 6
2021 BQ Journal Vol 42 - 7
2021 BQ Journal Vol 42 - 8
2021 BQ Journal Vol 42 - 9
2021 BQ Journal Vol 42 - 10
2021 BQ Journal Vol 42 - 11
2021 BQ Journal Vol 42 - 12
2021 BQ Journal Vol 42 - 13
2021 BQ Journal Vol 42 - 14
2021 BQ Journal Vol 42 - 15
2021 BQ Journal Vol 42 - 16
2021 BQ Journal Vol 42 - 17
2021 BQ Journal Vol 42 - 18
2021 BQ Journal Vol 42 - 19
2021 BQ Journal Vol 42 - 20
2021 BQ Journal Vol 42 - 21
2021 BQ Journal Vol 42 - 22
2021 BQ Journal Vol 42 - 23
2021 BQ Journal Vol 42 - 24
2021 BQ Journal Vol 42 - 25
2021 BQ Journal Vol 42 - 26
2021 BQ Journal Vol 42 - 27
2021 BQ Journal Vol 42 - 28
2021 BQ Journal Vol 42 - 29
2021 BQ Journal Vol 42 - 30
2021 BQ Journal Vol 42 - 31
2021 BQ Journal Vol 42 - 32
2021 BQ Journal Vol 42 - 33
2021 BQ Journal Vol 42 - 34
2021 BQ Journal Vol 42 - 35
2021 BQ Journal Vol 42 - 36
2021 BQ Journal Vol 42 - 37
2021 BQ Journal Vol 42 - 38
2021 BQ Journal Vol 42 - 39
2021 BQ Journal Vol 42 - 40
2021 BQ Journal Vol 42 - 41
2021 BQ Journal Vol 42 - 42
2021 BQ Journal Vol 42 - 43
2021 BQ Journal Vol 42 - Cover4
https://www.nxtbook.com/nxtbooks/henryschein/practicepinkflyer_slimjim2021
https://www.nxtbook.com/nxtbooks/henryschein/bqjournal_q3_2021
https://www.nxtbook.com/nxtbooks/henryschein/pharmaceutical_guide_2021
https://www.nxtbook.com/nxtbooks/henryschein/wfg_flu_sale_flyer_2021
https://www.nxtbook.com/nxtbooks/henryschein/medical_annual_ref_guide_2021
https://www.nxtbook.com/nxtbooks/henryschein/equipmenttabloid_q2_2021
https://www.nxtbook.com/nxtbooks/henryschein/bqjournal_q2_2021
https://www.nxtbook.com/nxtbooks/henryschein/medical_federal_flyer_2021spring
https://www.nxtbook.com/nxtbooks/henryschein/medsurg_slimjim_q2_2021
https://www.nxtbook.com/nxtbooks/henryschein/ssnfa_catalog_20212022
https://www.nxtbook.com/nxtbooks/henryschein/sherman_flyer_2021
https://www.nxtbook.com/nxtbooks/henryschein/pol_2021
https://www.nxtbook.com/nxtbooks/henryschein/bqjournal_q1_2021
https://www.nxtbook.com/nxtbooks/henryschein/medsurg_slimjim_q12021
https://www.nxtbook.com/nxtbooks/henryschein/wfg_sale_flyer_2021
https://www.nxtbook.com/nxtbooks/henryschein/medsurg_slimjim_q42020
https://www.nxtbook.com/nxtbooks/henryschein/lab_tabloid_fallwinter2020
https://www.nxtbook.com/nxtbooks/henryschein/equipmenttabloid_fallwinter2020
https://www.nxtbook.com/nxtbooks/henryschein/featuredproductguide_q4_20
https://www.nxtbook.com/nxtbooks/henryschein/medical_federal_flyer_2020
https://www.nxtbook.com/nxtbooks/henryschein/pediatricspotlight_2020
https://www.nxtbook.com/nxtbooks/henryschein/pharmaceutical_guide_2020
https://www.nxtbook.com/nxtbooks/henryschein/featuredproductguide_q3_20
https://www.nxtbook.com/nxtbooks/henryschein/radiology_imaging2020
https://www.nxtbook.com/nxtbooks/henryschein/bqjournal_q3_2020
https://www.nxtbook.com/nxtbooks/henryschein/wfg_sale_flyer_2020
https://www.nxtbook.com/nxtbooks/henryschein/asc_spotlight_2020
https://www.nxtbook.com/nxtbooks/henryschein/equipmenttabloid_spring2020
https://www.nxtbook.com/nxtbooks/henryschein/gems_q22020
https://www.nxtbook.com/nxtbooks/henryschein/criteriongloves
https://www.nxtbook.com/nxtbooks/henryschein/incontrolslimjim_q12020
https://www.nxtbook.com/nxtbooks/henryschein/gems_q12020
https://www.nxtbook.com/nxtbooks/henryschein/asc_spotlight_2019q3
https://www.nxtbook.com/nxtbooks/henryschein/featuredproductguide_q1_19
https://www.nxtbook.com/nxtbooks/henryschein/featuredproductguide_q2_19
https://www.nxtbook.com/nxtbooks/henryschein/generalmedflyer_q3_2019
https://www.nxtbook.com/nxtbooks/henryschein/generalmedflyer_q4_2019
https://www.nxtbook.com/nxtbooks/henryschein/springequipmenttabloid_2019
https://www.nxtbook.com/nxtbooks/henryschein/equipmenttabloid_2019
https://www.nxtbook.com/nxtbooks/henryschein/radiology_imaging2019
https://www.nxtbook.com/nxtbooks/henryschein/pharmaceutical_guide_2019
https://www.nxtbook.com/nxtbooks/henryschein/vaccine_guide_2019
https://www.nxtbook.com/nxtbooks/henryschein/mmcap_2019
https://www.nxtbookmedia.com